KO Cancer Act

Knock Out Cancer Act or the KO Cancer Act

This bill provides additional funding through FY2027 to the National Institutes of Health (NIH) for cancer research. The amount of additional funding each fiscal year is equal to 25% of the total amount allocated to the NIH for cancer research in FY2021.

The KO Cancer Act, also known as Bill 117 hr 6342, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to increase funding for cancer research and treatment in order to improve outcomes for patients and ultimately find a cure for cancer.

If passed, the KO Cancer Act would allocate additional resources to the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to support research on various types of cancer. This funding would be used to develop new treatments, improve early detection methods, and enhance patient care.

In addition to funding research, the bill also aims to increase access to cancer screenings and treatment for underserved communities. This includes providing grants to community health centers and other organizations that serve low-income and minority populations. Furthermore, the KO Cancer Act includes provisions to improve coordination and collaboration among different agencies and organizations involved in cancer research and treatment. This would help streamline efforts and ensure that resources are being used effectively to combat this disease. Overall, the KO Cancer Act is a comprehensive piece of legislation that seeks to address the challenges of cancer prevention, diagnosis, and treatment. If passed, it has the potential to make significant strides in the fight against cancer and improve the lives of millions of Americans affected by this disease.